• RESOURCES
  • Products
    products details
    Home > Products >
    Mastoparan Peptide Toxins Catalog Number KS201001 CAS 72093-21-1

    Mastoparan Peptide Toxins Catalog Number KS201001 CAS 72093-21-1

    Product Details:
    Catalog Number:
    KS201001
    Product Name:
    Mastoparan
    Scale:
    1mg
    Price:
    $48
    Purity:
    ≥95%
    Channel Type:
    Other Blockers
    Molecular N/AFormula:
    N/A
    Molecular Weight:
    N/A
    Form:
    Lyophilized
    Storage:
    Store At -20°C Or -80°C
    High Light: 

    Mastoparan Peptide Toxins

    ,

    Peptide Toxins 72093-21-1

    ,

    Mastoparan Peptide

    Product Description

    Mastoparan,Catalog Number: KS201001,CAS#72093-21-1,Lyophilized,Purity≥95%

     

    Mastoparan, a tetradecapeptide which is a component of wasp venom, activates Gi and Go and has been shown to cause an increase in the production of Arachidonic Acid catalyzed by PLA2 from porcine pancreas and bee venom.

    Mastoparan is a peptide toxin from wasp venom. It has the chemical structure Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2.

     

    The net effect of mastoparan's mode of action depends on cell type, but seemingly always involves exocytosis. In mast cells, this takes the form of histamine secretion, while in platelets and chromaffin cells release serotonin and catecholamines are found, respectively. Mastoparan activity in the anterior pituitary gland leads to prolactin release.

     

    In the case of histamine secretion, the effect of mastoparan takes place via its interference with G protein activity. By stimulating the GTPase activity of certain subunits, mastoparan shortens the lifespan of active G protein. At the same time, it promotes dissociation of any bound GDP from the protein, enhancing GTP binding. In effect, the GTP turnover of G proteins is greatly increased by mastoparan. These properties of the toxin follow from the fact that it structurally resembles activated G protein receptors when placed in a phospholipid environment. The resultant G protein-mediated signaling cascade leads to intracellular IP3 release and the resultant influx of Ca2+.

     

    Research has shown that Mastoparan inhibits all developmental forms of Trypanosoma cruzi, the parasite that is responsible for Chagas disease.

    Products
    products details
    Home > Products >
    Mastoparan Peptide Toxins Catalog Number KS201001 CAS 72093-21-1

    Mastoparan Peptide Toxins Catalog Number KS201001 CAS 72093-21-1

    Product Details:
    Catalog Number:
    KS201001
    Product Name:
    Mastoparan
    Scale:
    1mg
    Price:
    $48
    Purity:
    ≥95%
    Channel Type:
    Other Blockers
    Molecular N/AFormula:
    N/A
    Molecular Weight:
    N/A
    Form:
    Lyophilized
    Storage:
    Store At -20°C Or -80°C
    Details Link:
    Https://shopping.ks-vpeptide.com/sale-470933-mastoparan-peptide-toxins-catalog-number-ks201001-cas-72093-21-1.htm
    High Light: 

    Mastoparan Peptide Toxins

    ,

    Peptide Toxins 72093-21-1

    ,

    Mastoparan Peptide

    Product Description

    Mastoparan,Catalog Number: KS201001,CAS#72093-21-1,Lyophilized,Purity≥95%

     

    Mastoparan, a tetradecapeptide which is a component of wasp venom, activates Gi and Go and has been shown to cause an increase in the production of Arachidonic Acid catalyzed by PLA2 from porcine pancreas and bee venom.

    Mastoparan is a peptide toxin from wasp venom. It has the chemical structure Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2.

     

    The net effect of mastoparan's mode of action depends on cell type, but seemingly always involves exocytosis. In mast cells, this takes the form of histamine secretion, while in platelets and chromaffin cells release serotonin and catecholamines are found, respectively. Mastoparan activity in the anterior pituitary gland leads to prolactin release.

     

    In the case of histamine secretion, the effect of mastoparan takes place via its interference with G protein activity. By stimulating the GTPase activity of certain subunits, mastoparan shortens the lifespan of active G protein. At the same time, it promotes dissociation of any bound GDP from the protein, enhancing GTP binding. In effect, the GTP turnover of G proteins is greatly increased by mastoparan. These properties of the toxin follow from the fact that it structurally resembles activated G protein receptors when placed in a phospholipid environment. The resultant G protein-mediated signaling cascade leads to intracellular IP3 release and the resultant influx of Ca2+.

     

    Research has shown that Mastoparan inhibits all developmental forms of Trypanosoma cruzi, the parasite that is responsible for Chagas disease.